GB1336015A - Rearing pigs - Google Patents

Rearing pigs

Info

Publication number
GB1336015A
GB1336015A GB2674670A GB1336015DA GB1336015A GB 1336015 A GB1336015 A GB 1336015A GB 2674670 A GB2674670 A GB 2674670A GB 1336015D A GB1336015D A GB 1336015DA GB 1336015 A GB1336015 A GB 1336015A
Authority
GB
United Kingdom
Prior art keywords
endotoxins
coli
pig
feed
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2674670A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC filed Critical Unilever PLC
Publication of GB1336015A publication Critical patent/GB1336015A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1336015 E. coli endotoxins UNILEVER Ltd 2 June 1971 [3 June 1970] 26746/70 Heading A5B Pigs are treated to improve their resistance to gastro-intestinal disorders by introducing into the pig intestine, by way of the mouth, the endotoxins of one or more of the Escherichia coli serotypes 08, 045, 0138, 0139, 0141, 0147 and 0149, free from the living E. coli organisms. The endotoxins may be administered in water or in a pig feed before the pig is weaned, in particular administration is begun at the age of 4 to 10 days. Pig feed compositions comprise one or more, preferably all seven, of the E. coli serotypes and a nutrient material, preferably comprising a protein, a carbohydrate source, vitamins and/or mineral elements. The endotoxins may be obtained by culturing the E. coli serotype, separating from the culture the bacteria grown in it, and killing the separated bacteria, e.g. by heat, to cause release of endotoxins, the endotoxins remaining bound to the killed bacteria being released by treatment with an enzyme such as trypsin, lysozyme, pepsin or lipase. The pig feed may be prepared by making an aqueous premix of endotoxins and one or more of the ingredients of the feed at pH 5 to 6 and mixing the premix with the other ingredients of the feed.
GB2674670A 1970-06-03 1970-06-03 Rearing pigs Expired GB1336015A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2674670 1970-06-03

Publications (1)

Publication Number Publication Date
GB1336015A true GB1336015A (en) 1973-11-07

Family

ID=10248578

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2674670A Expired GB1336015A (en) 1970-06-03 1970-06-03 Rearing pigs

Country Status (13)

Country Link
BE (1) BE768078A (en)
CA (1) CA979806A (en)
DE (1) DE2125641C2 (en)
DK (1) DK144083C (en)
ES (2) ES391698A1 (en)
FR (1) FR2119903B1 (en)
GB (1) GB1336015A (en)
IE (1) IE35321B1 (en)
IT (1) IT1024507B (en)
NL (1) NL7107538A (en)
SE (1) SE421173C (en)
YU (1) YU42918B (en)
ZA (1) ZA713510B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139618A (en) * 1975-05-07 1976-12-02 Unilever Nv Treatment of animal
WO2008106763A1 (en) * 2007-03-08 2008-09-12 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789864A (en) * 1971-10-14 1973-04-09 Unilever Nv CALF BREEDING
US4285931A (en) 1978-01-30 1981-08-25 Merck & Co., Inc. E. coli enterotoxin vaccine for veterinary and human use
FR2466251B1 (en) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech ANTI-COLIBACILLAR VACCINE, OBTAINMENT AND APPLICATION
CH639852A5 (en) * 1979-07-26 1983-12-15 Om Laboratoires Sa MEDICINE AGAINST INFECTIOUS DISEASES OF THE URINARY AND DIGESTIVE PATHWAYS.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD62894A (en) *
CA768129A (en) * 1967-09-26 M. Berger Frank Endotoxin fractions and method for producing same
DE1792256C3 (en) * 1968-08-10 1979-07-05 Kali-Chemie Pharma Gmbh, 3000 Hannover Orally administered, polyvalent vaccines against local intestinal infections

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139618A (en) * 1975-05-07 1976-12-02 Unilever Nv Treatment of animal
WO2008106763A1 (en) * 2007-03-08 2008-09-12 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
US8920814B2 (en) 2007-03-08 2014-12-30 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections

Also Published As

Publication number Publication date
IE35321B1 (en) 1976-01-07
YU42918B (en) 1989-02-28
ES417901A1 (en) 1976-06-16
IT1024507B (en) 1978-07-20
FR2119903B1 (en) 1974-10-18
SE421173C (en) 1985-10-28
YU137171A (en) 1982-02-28
DE2125641C2 (en) 1986-03-13
DK144083B (en) 1981-12-07
ZA713510B (en) 1973-01-31
DK144083C (en) 1989-11-20
ES391698A1 (en) 1975-07-16
BE768078A (en) 1971-12-03
CA979806A (en) 1975-12-16
NL7107538A (en) 1971-12-07
SE421173B (en) 1981-12-07
FR2119903A1 (en) 1972-08-11
IE35321L (en) 1971-12-03
DE2125641A1 (en) 1971-12-09

Similar Documents

Publication Publication Date Title
US3320130A (en) Medicament for colitis, gastroenteritis and enterocolitis
US4689226A (en) Process for the production of a bacterial preparation for the prophylaxis of intestinal disturbances in poultry
US3984575A (en) Bacterial compositions for changing the digestive system bacteria in animals
US4767623A (en) Method of binding microflora and preparations therefor
JPS63209580A (en) Bacillus subtilis c-3102
GB1300446A (en) Improvements in or relating to processes of producing compositions for controlling the bacterial flora in the intestines of human beings and animals
US3953609A (en) Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628
GB1336015A (en) Rearing pigs
Cunningham et al. The effect of proteolytic enzymes on the utilization of animal and plant proteins by newborn pigs and the response to predigested protein
ES300578A2 (en) Procedure for the elaboration of a product of high biological value intended for its incorporation to feeds, preferably for monogastricos (Machine-translation by Google Translate, not legally binding)
GB1462384A (en) Rearing of lambs
JPH04193832A (en) Preventive and treating agent of microbism in fishes and crustacea
Umphrey et al. General anatomy of the ruminant digestive system
Slinger et al. The correlation between feed consumption and fecal flora in chicks
JPS6055098B2 (en) horse feed additives
JP2621588B2 (en) Prevention and treatment of white and diarrhea in livestock
CN1058377C (en) Fowl and animal fodder additive with seed bacteria prepared by mixing various living bacteria for processing food
JPS5894353A (en) Feed additive containing physiologically active substance
GB1401280A (en) Compositions and method for improving the resistance of calves to intestinal disorders
RU2339388C2 (en) Method for prevention of subclinical mastitis at sows during pregnancy
CN113615773B (en) Feed additive containing lysozyme and traditional Chinese medicine extracts
KR100271850B1 (en) Method for culture of lactobacillus casei
Bakun Prevention of gastrointestinal diseases in piglets at weaning using probiotics Bacillus coagylans and Bacillus megaterium
JPH08333263A (en) Animal growth-promoting agent
RU161526U1 (en) BIOLOGICAL PRODUCT FOR PREVENTION AND TREATMENT OF AGRICULTURAL ANIMAL DISEASES ON THE BACKGROUND OF INTESTINAL BIOCENOSIS DISORDERS

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years